Biogen Inc.

Insider Reports History

Entity
Company
Location
225 Binney Street, Cambridge, MA
Signature
BIOGEN INC. By: /s/ Michael Dambach, Vice President and Treasurer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Biogen Inc.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SANGAMO THERAPEUTICS, INC 10%+ Owner Common Stock 17.7M $6.75M $0.38 Sep 26, 2023 By Biogen MA Inc.
REATA PHARMACEUTICALS INC Other* Class A common stock 0 $172.03 Jul 28, 2023 Indirect

Insider Reports Filed by Biogen Inc.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGMO SANGAMO THERAPEUTICS, INC Sep 26, 2023 1 -$3M 4 Sep 28, 2023 10%+ Owner
RETA REATA PHARMACEUTICALS INC Jul 28, 2023 0 $0 3 Aug 7, 2023 Other*
SGMO SANGAMO THERAPEUTICS, INC Aug 29, 2022 2 -$2.66M 4 Aug 31, 2022 10%+ Owner
SGMO SANGAMO THERAPEUTICS, INC Dec 28, 2021 1 -$23.5K 4 Dec 30, 2021 10%+ Owner
SGMO SANGAMO THERAPEUTICS, INC Dec 23, 2021 2 -$700K 4 Dec 28, 2021 10%+ Owner
SGMO SANGAMO THERAPEUTICS, INC Dec 9, 2021 1 -$203K 4 Dec 10, 2021 10%+ Owner
SGMO SANGAMO THERAPEUTICS, INC Dec 7, 2021 2 -$1.1M 4 Dec 9, 2021 10%+ Owner
SGMO SANGAMO THERAPEUTICS, INC Dec 1, 2021 2 -$22.2K 4 Dec 3, 2021 10%+ Owner
SGMO SANGAMO THERAPEUTICS, INC Nov 26, 2021 1 -$248K 4 Nov 30, 2021 10%+ Owner